Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: PAREXEL | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: PAREXEL

Revenues up 25% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL

2Q Revenues: $483.1 million (+25%)

2Q Earnings: $21.3 million (+65%)

YTD Revenues: $945.7 million (+26%)

YTD Earnings: $36.4 million (+62%)

Comments: Clinical Research Services (CRS) revenue was $320.6 million in the quarter, up 29%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $49.3 million, up 28%. Perceptive Informatics (PI) revenues were $101.4 million, up 12%. Newly-acquired Liquent, Inc. contributed $0.4 million to revenue in the quarter. Backlog at the end of December 2012 was approximately $4.5 billion, up 21%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters